StockNews.com assumed coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Free Report) in a research report report published on Saturday morning. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Price Performance DFFN opened at $2.92 on Friday. The stock has a market cap of $5.96 million, a P/E ratio of -0.38 and […]
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Free Report) saw a large decline in short interest in the month of June. As of June 15th, there was short interest totalling 4,900 shares, a decline of 23.4% from the May 31st total of 6,400 shares. Based on an average trading volume of 8,000 shares, the days-to-cover ratio is […]
StockNews.com started coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Free Report) in a research note published on Friday. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Price Performance Shares of DFFN opened at $3.34 on Friday. The business’s fifty day moving average price is $3.79 and its 200 day moving average […]
StockNews.com began coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a report released on Thursday. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Performance DFFN stock opened at $3.53 on Thursday. Diffusion Pharmaceuticals has a fifty-two week low of $3.42 and a fifty-two week high of $8.74. The […]
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Rating) was the recipient of a significant decrease in short interest during the month of May. As of May 31st, there was short interest totalling 6,400 shares, a decrease of 34.0% from the May 15th total of 9,700 shares. Approximately 0.3% of the company’s stock are sold short. Based […]